-
Education Resource
Behind the Story: Rio's Pentecostal Drug Gangs
Just a generation ago, born-again Christians were uncommon in Brazil. Now, nearly a third of the...
-
Mato Grosso has experienced mortality rates above the national average and an underdeveloped...
-
In January 2020, The Agribusiness Watch ( De Olho nos Ruralistas) released its major journalistic...
-
Project
Shipibo-Konibo: An Indigenous Community Resists With Medicinal Plants Against the COVID-19 Virus
Awareness linked to plants is in danger of disappearing.
-
Pulitzer Center Update
Rainforest Journalism Fund Website Launches with Tools for Journalists
Multilingual site supports all five languages spoken in rainforest regions.
October 22, 2020
![A nurse prepares to inoculate volunteer Ilya Dubrovin, 36, with Russia's new coronavirus vaccine in a post-registration trials at a clinic in Moscow on September 10, 2020. Russia announced last month that its vaccine, named "Sputnik V" after the Soviet-era satellite that was the first launched into space in 1957, had already received approval. The vaccine was developed by the Gamaleya research institute in Moscow in coordination with the Russian Defence Ministry. Image by Natalia Kolesnikova/AFP. Russia,…](/sites/default/files/styles/510x315/public/11-05-20/marcano_1.jpg.webp?h=a411d77e&itok=cIVwM0Ag "A nurse prepares to inoculate volunteer Ilya Dubrovin, 36, with Russia's new coronavirus vaccine in a post-registration trials at a clinic in Moscow on September 10, 2020. Russia announced last month that its vaccine, named "Sputnik V" after the Soviet-era satellite that was the first launched into space in 1957, had already received approval. The vaccine was developed by the Gamaleya research institute in Moscow in coordination with the Russian Defence Ministry. Image by Natalia Kolesnikova/AFP. Russia, 2020.")
